Network and Showcase Your Research
This is an informal session to help you connect with your peers in a relaxed atmosphere to continue forging new and beneficial relationships. With an audience of biopharma and academic experts eager to hear the latest data on next-generation design and combination approaches alongside novel clinical trial methodologies and strategies for improved tolerability. You will have the opportunity to display a poster presenting your own GLP-1 therapeutics research. Don’t miss out on the chance to connect, learn, and present.
- Demonstrate your thought leadership in this dynamic field of metabolic medicine
- Gain visibility and exposure in showcasing your innovations in combination GLP-1 therapies across indications
- Engage in meaningful discussions with industry peers to receive direct feedback on clinical development strategies
- Attract the attention of industry stakeholders and collaborators dedicated to the GLP-1 pipeline
How to Submit Your Poster
- You must first register your place to attend the 3rd GLP-1 Based Therapeutics Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: April 15, 2026
T&Cs
- Posters should not be used for sales and marketing purposes
- If your company offers pay-for services, you will need to submit your poster request to our partnerships team - [email protected]
- All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions
Explore the Full Event Guide
- Analyze clinical strategies for reducing adverse GI effects and optimizing the side effect profile to improve patient comfort ensuring greater medication adherence
- Access advanced research and clinical insights on emerging multi-agonists (e.g., GLP-1/GCG/Amylin) and pharmacogenetics (PMX)
- Explore sessions dedicated to gaining the commercial and clinical blueprint for pioneering GLP-1 therapies in new frontiers
- Strategically apply collated insights from recent FDA-approved drugs and successful trial data
- Discover two focused, practical workshops that will provide actionable strategies on drug modelling and design
